Event: copyright protection and gene sequences
13 September 2016, London Post-Brexit and with escalating costs of patents and no Unified Patents Court, we ask might copyright protection offer a more cost-effective protection to recombinant derived small molecule pharmaceuticals? Mark Engelman, Michael Kock and Martin Gouldstone will cover the following topics: IP Protection for DNA Sequences: Patents vs. Copyright – Challenges, Limitations, Opportunities Legal developments in […]